160 related articles for article (PubMed ID: 20447506)
1. Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa.
Kiuru M; Itoh M; Cairo MS; Christiano AM
Dermatol Clin; 2010 Apr; 28(2):371-82, xii-xiii. PubMed ID: 20447506
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.
Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J
Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184
[TBL] [Abstract][Full Text] [Related]
3. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.
Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y
J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
Liao Y; Ivanova L; Sivalenka R; Plumer T; Zhu H; Zhang X; Christiano AM; McGrath JA; Gurney JP; Cairo MS
Stem Cells Transl Med; 2018 Jul; 7(7):530-542. PubMed ID: 29745997
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.
Tolar J; Xia L; Riddle MJ; Lees CJ; Eide CR; McElmurry RT; Titeux M; Osborn MJ; Lund TC; Hovnanian A; Wagner JE; Blazar BR
J Invest Dermatol; 2011 Apr; 131(4):848-56. PubMed ID: 21124339
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
Tolar J; Ishida-Yamamoto A; Riddle M; McElmurry RT; Osborn M; Xia L; Lund T; Slattery C; Uitto J; Christiano AM; Wagner JE; Blazar BR
Blood; 2009 Jan; 113(5):1167-74. PubMed ID: 18955559
[TBL] [Abstract][Full Text] [Related]
7. Cell-based therapy for RDEB: how does it work?
Uitto J
J Invest Dermatol; 2011 Aug; 131(8):1597-9. PubMed ID: 21753764
[TBL] [Abstract][Full Text] [Related]
8. Placenta-based therapies for the treatment of epidermolysis bullosa.
Nevala-Plagemann C; Lee C; Tolar J
Cytotherapy; 2015 Jun; 17(6):786-795. PubMed ID: 25795271
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.
Wagner JE; Ishida-Yamamoto A; McGrath JA; Hordinsky M; Keene DR; Woodley DT; Chen M; Riddle MJ; Osborn MJ; Lund T; Dolan M; Blazar BR; Tolar J
N Engl J Med; 2010 Aug; 363(7):629-39. PubMed ID: 20818854
[TBL] [Abstract][Full Text] [Related]
10. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial.
El-Darouti M; Fawzy M; Amin I; Abdel Hay R; Hegazy R; Gabr H; El Maadawi Z
Dermatol Ther; 2016; 29(2):96-100. PubMed ID: 26439431
[TBL] [Abstract][Full Text] [Related]
11. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.
Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS
Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
13. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
14. Interrogation of RDEB Epidermal Allografts after BMT Reveals Coexpression of Collagen VII and Keratin 15 with Proinflammatory Immune Cells and Fibroblasts.
Riedl JA; Riddle M; Xia L; Eide C; Boull C; Ebens CL; Tolar J
J Invest Dermatol; 2022 Sep; 142(9):2424-2434. PubMed ID: 35304249
[TBL] [Abstract][Full Text] [Related]
15. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
16. Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.
Watt SA; Dayal JH; Wright S; Riddle M; Pourreyron C; McMillan JR; Kimble RM; Prisco M; Gartner U; Warbrick E; McLean WH; Leigh IM; McGrath JA; Salas-Alanis JC; Tolar J; South AP
PLoS One; 2015; 10(9):e0137639. PubMed ID: 26380979
[TBL] [Abstract][Full Text] [Related]
17. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
[TBL] [Abstract][Full Text] [Related]
18. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.
Cogan J; Weinstein J; Wang X; Hou Y; Martin S; South AP; Woodley DT; Chen M
Mol Ther; 2014 Oct; 22(10):1741-52. PubMed ID: 25155989
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa.
Tolar J; McGrath JA; Xia L; Riddle MJ; Lees CJ; Eide C; Keene DR; Liu L; Osborn MJ; Lund TC; Blazar BR; Wagner JE
J Invest Dermatol; 2014 May; 134(5):1246-1254. PubMed ID: 24317394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
